Soluble PD-1 delivery has successfully improved the cytotoxicity of tumor-specific CTLs induced by the local gene delivery of secondary lymphoid chemokine (CCL21) using eukaryotic expression plasmids (pSLC) (163). This evidence concerns the gene PDCD1 and neoplasm.